Saturday 31 October 2026 Export LLY’s income statement to Excel — free account

Eli Lilly and Company

LLY Healthcare Drug Manufacturers General

Eli Lilly and Company’s revenue for fiscal 2025 (year ended December 2025) was $65.2 billion, up 44.7% from fiscal 2024. In the quarter to June 2026, revenue grew 47.7%, EPS grew 26.2%, free cash flow grew 458.1% and total debt rose 37.6%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for five.

1,415.16 41.46 +3.02%

Follow LLY

Alert me

Market cap: $1.29T
P/E: 47.5×
Fwd P/E: 36.7×
Dividend yield: 0.47%
F-score: 7/9
Altman Z: 8.61
Beneish M: −1.91
Dividend safety: 86/100

Overview Business Profile Earnings & Analysis Segments Filings

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	40.25	32.67	46.83	37.33	+8 more quarters Free account
P/S ratio Full definition →	13.44	11.39	14.79	11.52
P/FCF ratio Full definition →	52.49	58.67	86.31	59.65
P/Operating CF Full definition →	100.13	154.27	299.05	77.45
P/B ratio Full definition →	31.59	26.37	36.34	28.69
Price to Tangible BV Full definition →	154.68	46.50	68.31	59.48
EV/Sales Full definition →	14.01	11.88	15.34	12.13
EV/EBITDA Full definition →	31.24	25.58	35.32	29.38
EV/Operating CF Full definition →	39.75	41.92	59.45	44.89
EV/FCF Full definition →	54.75	61.21	89.46	62.85
Quick Ratio Full definition →	0.68	0.72	0.78	0.73
Current Ratio Full definition →	1.35	1.50	1.58	1.55
Net Debt/EBITDA Full definition →	4.83	3.62	3.93	3.95
Debt/Assets Full definition →	38.59%	33.77%	37.79%	35.56%
Debt/Equity Full definition →	1.62	1.26	1.60	1.71
Asset Turnover Full definition →	0.66	0.70	0.68	0.62
Operating CF/Net income Full definition →	1.51	0.72	0.49	1.58
Capex/Depreciation Full definition →	(5.49)	(4.57)	(4.35)	(4.44)
Research and Development Expense of Revenue Full definition →	16.62%	17.73%	19.70%	19.69%
Selling, General and Administrative Expense of Revenue Full definition →	14.93%	14.82%	16.24%	15.57%
Intangible Assets out of Total Assets Full definition →	0.19	0.12	0.11	0.11
Share Based Compensation of Revenue Full definition →	0.87%	0.81%	0.71%	0.86%
Graham Net Nets Full definition →	(0.04)	(0.04)	(0.03)	(0.04)
Graham Number Full definition →	159.55	148.63	123.57	110.59
Earnings Yield Full definition →	2.48%	3.06%	2.14%	2.68%
Free Cash Flow Yield Full definition →	1.91%	1.70%	1.16%	1.68%
Revenue per Share Full definition →	25.74	22.13	21.50	19.62
Operating CF per Share Full definition →	11.98	5.96	3.59	9.85
Capex per Share Full definition →	(3.29)	(2.60)	(2.84)	(2.33)
Free Cash Flow per Share Full definition →	8.69	3.36	0.76	7.52
Cash per Share Full definition →	10.03	5.91	8.10	11.05
Shareholders Equity per Share Full definition →	37.96	34.88	29.57	26.59
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	37.96	34.88	29.57	26.59
Free Cash Flow Full definition →	7,757.00	3,007.00	677.90	6,748.10
Working Capital Full definition →	16,931.00	18,201.00	20,401.00	21,930.40
Capital Expenditures Full definition →	(2,933.00)	(2,326.00)	(2,546.70)	(2,087.30)
Net Current Asset Value Full definition →	(43,732.00)	(30,543.00)	(30,312.00)	(29,013.30)
EV/EBIT Full definition →	33.19	27.23	38.00	31.85
Capex to Sales Full definition →	0.13	0.12	0.13	0.12
Price to Operating Income Full definition →	31.83	26.10	36.66	30.23
Other line items
Average Receivables Full definition →	20,340.30	17,590.10	16,715.50	15,754.45
Average Payables Full definition →	5,093.85	4,235.50	4,304.00	3,574.35
Average Inventory Full definition →	13,903.40	11,920.00	10,666.50	9,820.10
Average Assets Full definition →	121,602.80	102,982.40	95,595.50	95,271.15
Average Common Equity Full definition →	26,114.05	23,522.40	20,403.50	19,085.75

Show all line items

Columns are period end dates

Stockrow Weekly